{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:47:22Z","timestamp":1774630042892,"version":"3.50.1"},"reference-count":48,"publisher":"American Association for Cancer Research (AACR)","issue":"1","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Purpose: To evaluate aberrant promoter hypermethylation of candidate tumor suppressor genes as a means to detect epigenetic alterations specific to solid tumors, including head and neck squamous cell carcinoma (HNSCC).<\/jats:p>\n                  <jats:p>Experimental Design: Using promoter regions identified via a candidate gene and discovery approach, we evaluated the ability of an expanded panel of CpG-rich promoters known to be differentially hypermethylated in HNSCC in detection of promoter hypermethylation in serum and salivary rinses associated with HNSCC. We did preliminary evaluation via quantitative methylation-specific PCR (Q-MSP) using a panel of 21 genes in a limited cohort of patients with HNSCC and normal controls. Using sensitivity and specificity for individual markers as criteria, we selected panels of eight and six genes, respectively, for use in salivary rinse and serum detection and tested these in an expanded cohort including up to 211 patients with HNSCC and 527 normal controls.<\/jats:p>\n                  <jats:p>Results: Marker panels in salivary rinses showed improved detection when compared with single markers, including a panel with 35% sensitivity and 90% specificity and a panel with 85% sensitivity and 30% specificity. A similar pattern was noted in serum panels, including a panel with 84.5% specificity with 50.0% sensitivity and a panel with sensitivity of 81.0% with specificity of 43.5%. We also noted that serum and salivary rinse compartments showed a differential pattern of methylation in normal subjects that influenced the utility of individual markers.<\/jats:p>\n                  <jats:p>Conclusions: Q-MSP detection of HNSCC in serum and salivary rinses using multiple targets offers improved performance when compared with single markers. Compartment-specific methylation in normal subjects affects the utility of Q-MSP detection strategies.<\/jats:p>","DOI":"10.1158\/1078-0432.ccr-07-0722","type":"journal-article","created":{"date-parts":[[2008,1,2]],"date-time":"2008-01-02T20:58:13Z","timestamp":1199307493000},"page":"97-107","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":150,"title":["Evaluation of Promoter Hypermethylation Detection in Body Fluids as a Screening\/Diagnosis Tool for Head and Neck Squamous Cell Carcinoma"],"prefix":"10.1158","volume":"14","author":[{"given":"Andre\u0301 Lopes","family":"Carvalho","sequence":"first","affiliation":[{"name":"1Otolaryngology-Head and Neck Surgery and Departments of"}]},{"given":"Carmen","family":"Jeronimo","sequence":"additional","affiliation":[{"name":"1Otolaryngology-Head and Neck Surgery and Departments of"}]},{"given":"Michael M.","family":"Kim","sequence":"additional","affiliation":[{"name":"1Otolaryngology-Head and Neck Surgery and Departments of"}]},{"given":"Rui","family":"Henrique","sequence":"additional","affiliation":[{"name":"1Otolaryngology-Head and Neck Surgery and Departments of"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[{"name":"3Division of Oncology Biostatistics, Johns Hopkins Medical Institutions, Baltimore, Maryland"}]},{"given":"Mohammad O.","family":"Hoque","sequence":"additional","affiliation":[{"name":"1Otolaryngology-Head and Neck Surgery and Departments of"}]},{"given":"Steve","family":"Chang","sequence":"additional","affiliation":[{"name":"1Otolaryngology-Head and Neck Surgery and Departments of"}]},{"given":"Mariana","family":"Brait","sequence":"additional","affiliation":[{"name":"1Otolaryngology-Head and Neck Surgery and Departments of"}]},{"given":"Chetan S.","family":"Nayak","sequence":"additional","affiliation":[{"name":"1Otolaryngology-Head and Neck Surgery and Departments of"}]},{"given":"Wei-Wen","family":"Jiang","sequence":"additional","affiliation":[{"name":"1Otolaryngology-Head and Neck Surgery and Departments of"}]},{"given":"Quia","family":"Claybourne","sequence":"additional","affiliation":[{"name":"1Otolaryngology-Head and Neck Surgery and Departments of"}]},{"given":"Yutaka","family":"Tokumaru","sequence":"additional","affiliation":[{"name":"1Otolaryngology-Head and Neck Surgery and Departments of"}]},{"given":"Juna","family":"Lee","sequence":"additional","affiliation":[{"name":"1Otolaryngology-Head and Neck Surgery and Departments of"}]},{"given":"David","family":"Goldenberg","sequence":"additional","affiliation":[{"name":"1Otolaryngology-Head and Neck Surgery and Departments of"}]},{"given":"Elizabeth","family":"Garrett-Mayer","sequence":"additional","affiliation":[{"name":"1Otolaryngology-Head and Neck Surgery and Departments of"},{"name":"3Division of Oncology Biostatistics, Johns Hopkins Medical Institutions, Baltimore, Maryland"}]},{"given":"Steven","family":"Goodman","sequence":"additional","affiliation":[{"name":"3Division of Oncology Biostatistics, Johns Hopkins Medical Institutions, Baltimore, Maryland"}]},{"given":"Chul-so","family":"Moon","sequence":"additional","affiliation":[{"name":"1Otolaryngology-Head and Neck Surgery and Departments of"}]},{"given":"Wayne","family":"Koch","sequence":"additional","affiliation":[{"name":"1Otolaryngology-Head and Neck Surgery and Departments of"}]},{"given":"William H.","family":"Westra","sequence":"additional","affiliation":[{"name":"2Pathology and"}]},{"given":"David","family":"Sidransky","sequence":"additional","affiliation":[{"name":"1Otolaryngology-Head and Neck Surgery and Departments of"}]},{"given":"Joseph A.","family":"Califano","sequence":"additional","affiliation":[{"name":"1Otolaryngology-Head and Neck Surgery and Departments of"}]}],"member":"1086","published-online":{"date-parts":[[2008,1,2]]},"reference":[{"key":"2022061105452105200_B1","doi-asserted-by":"crossref","unstructured":"Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin\u20082006;56:106\u201330.","DOI":"10.3322\/canjclin.56.2.106"},{"key":"2022061105452105200_B2","unstructured":"National Cancer Institute (NCI). Oral cancer (PDQ\u00ae): screening. 2006."},{"key":"2022061105452105200_B3","doi-asserted-by":"crossref","unstructured":"Speight PM, Palmer S, Moles DR, et al. The cost-effectiveness of screening for oral cancer in primary care. Health Technol Assess\u20082006;10:1\u20134.","DOI":"10.3310\/hta10140"},{"key":"2022061105452105200_B4","unstructured":"Palmisano WA, Divine KK, Saccomanno G, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res\u20082000;60:5954\u20138."},{"key":"2022061105452105200_B5","doi-asserted-by":"crossref","unstructured":"Hoque MO, Begum S, Topaloglu O, et al. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. Cancer Res\u20082004;64:5511\u20137.","DOI":"10.1158\/0008-5472.CAN-04-0799"},{"key":"2022061105452105200_B6","doi-asserted-by":"crossref","unstructured":"Nunes DN, Kowalski LP, Simpson AJ. Detection of oral and oropharyngeal cancer by microsatellite analysis in mouth washes and lesion brushings. Oral Oncol\u20082000;36:525\u20138.","DOI":"10.1016\/S1368-8375(00)00045-2"},{"key":"2022061105452105200_B7","unstructured":"Rosas SL, Koch W, Costa Carvalho MG, et al. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res\u20082001;61:939\u201342."},{"key":"2022061105452105200_B8","doi-asserted-by":"crossref","unstructured":"El Naggar AK, Mao L, Staerkel G, et al. Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. J Mol Diagn\u20082001;3:164\u201370.","DOI":"10.1016\/S1525-1578(10)60668-X"},{"key":"2022061105452105200_B9","doi-asserted-by":"crossref","unstructured":"Lee A, Kim Y, Han K, Kang CS, Jeon HM, Shim SI. Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast. Arch Pathol Lab Med\u20082004;128:1251\u20136.","DOI":"10.5858\/2004-128-1251-DOTMIC"},{"key":"2022061105452105200_B10","unstructured":"Usadel H, Brabender J, Danenberg KD, et al. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res\u20082002;62:371\u20135."},{"key":"2022061105452105200_B11","doi-asserted-by":"crossref","unstructured":"Hu S, Ewertz M, Tufano RP, et al. Detection of serum deoxyribonucleic acid methylation markers: a novel diagnostic tool for thyroid cancer. J Clin Endocrinol Metab\u20082006;91:98\u2013104.","DOI":"10.1210\/jc.2005-1810"},{"key":"2022061105452105200_B12","unstructured":"Sanchez-Cespedes M, Esteller M, Wu L, et al. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res\u20082000;60:892\u20135."},{"key":"2022061105452105200_B13","unstructured":"Wong IH, Zhang J, Lai PB, Lau WY, Lo YM. Quantitative analysis of tumor-derived methylated p16INK4a sequences in plasma, serum, and blood cells of hepatocellular carcinoma patients. Clin Cancer Res\u20082003;9:1047\u201352."},{"key":"2022061105452105200_B14","doi-asserted-by":"crossref","unstructured":"Wadsworth JT, Somers KD, Stack BC, Jr., et al. Identification of patients with head and neck cancer using serum protein profiles. Arch Otolaryngol Head Neck Surg\u20082004;130:98\u2013104.","DOI":"10.1001\/archotol.130.1.98"},{"key":"2022061105452105200_B15","doi-asserted-by":"crossref","unstructured":"Clark SJ, Melki J. DNA methylation and gene silencing in cancer: which is the guilty party? Oncogene\u20082002;21:5380\u20137.","DOI":"10.1038\/sj.onc.1205598"},{"key":"2022061105452105200_B16","doi-asserted-by":"crossref","unstructured":"Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med\u20082003;349:2042\u201354.","DOI":"10.1056\/NEJMra023075"},{"key":"2022061105452105200_B17","doi-asserted-by":"crossref","unstructured":"Merlo A, Herman JG, Mao L, et al. 5\u2032 CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16\/CDKN2\/MTS1 in human cancers. Nat Med\u20081995;1:686\u201392.","DOI":"10.1038\/nm0795-686"},{"key":"2022061105452105200_B18","doi-asserted-by":"crossref","unstructured":"Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res\u20082001;61:3225\u20139.","DOI":"10.1007\/BF02979467"},{"key":"2022061105452105200_B19","doi-asserted-by":"crossref","unstructured":"Ha PK, Califano JA. Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. Lancet Oncol\u20082006;7:77\u201382.","DOI":"10.1016\/S1470-2045(05)70540-4"},{"key":"2022061105452105200_B20","doi-asserted-by":"crossref","unstructured":"Bernard PS, Wittwer CT. Real-time PCR technology for cancer diagnostics. Clin Chem\u20082002;48:1178\u201385.","DOI":"10.1093\/clinchem\/48.8.1178"},{"key":"2022061105452105200_B21","doi-asserted-by":"crossref","unstructured":"Eads CA, Danenberg KD, Kawakami K, et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res\u20082000;28:E32.","DOI":"10.1093\/nar\/28.8.e32"},{"key":"2022061105452105200_B22","doi-asserted-by":"crossref","unstructured":"Cottrell SE, Laird PW. Sensitive detection of DNA methylation. Ann N Y Acad Sci\u20082003;983:120\u201330.","DOI":"10.1111\/j.1749-6632.2003.tb05967.x"},{"key":"2022061105452105200_B23","doi-asserted-by":"crossref","unstructured":"Jeronimo C, Usadel H, Henrique R, et al. Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. J Natl Cancer Inst\u20082001;93:1747\u201352.","DOI":"10.1093\/jnci\/93.22.1747"},{"key":"2022061105452105200_B24","doi-asserted-by":"crossref","unstructured":"Belinsky SA, Liechty KC, Gentry FD, et al. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res\u20082006;66:3338\u201344.","DOI":"10.1158\/0008-5472.CAN-05-3408"},{"key":"2022061105452105200_B25","doi-asserted-by":"crossref","unstructured":"Lopez M, Aguirre JM, Cuevas N, et al. Gene promoter hypermethylation in oral rinses of leukoplakia patients\u2014a diagnostic and\/or prognostic tool? Eur J Cancer\u20082003;39:2306\u20139.","DOI":"10.1016\/S0959-8049(03)00550-1"},{"key":"2022061105452105200_B26","doi-asserted-by":"crossref","unstructured":"Chang HW, Chan A, Kwong DL, Wei WI, Sham JS, Yuen AP. Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal swab and peripheral blood of nasopharyngeal carcinoma patient. Int J Cancer\u20082003;105:851\u20135.","DOI":"10.1002\/ijc.11162"},{"key":"2022061105452105200_B27","doi-asserted-by":"crossref","unstructured":"Wong TS, Man MW, Lam AK, Wei WI, Kwong YL, Yuen AP. The study of p16 and p15 gene methylation in head and neck squamous cell carcinoma and their quantitative evaluation in plasma by real-time PCR. Eur J Cancer\u20082003;39:1881\u20137.","DOI":"10.1016\/S0959-8049(03)00428-3"},{"key":"2022061105452105200_B28","doi-asserted-by":"crossref","unstructured":"Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A\u20081996;93:9821\u20136.","DOI":"10.1073\/pnas.93.18.9821"},{"key":"2022061105452105200_B29","unstructured":"Harden SV, Tokumaru Y, Westra WH, et al. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients. Clin Cancer Res\u20082003;9:1370\u20135."},{"key":"2022061105452105200_B30","unstructured":"Chang HW, Chan A, Kwong DL, Wei WI, Sham JS, Yuen AP. Detection of hypermethylated RIZ1 gene in primary tumor, mouth, and throat rinsing fluid, nasopharyngeal swab, and peripheral blood of nasopharyngeal carcinoma patient. Clin Cancer Res\u20082003;9:1033\u20138."},{"key":"2022061105452105200_B31","doi-asserted-by":"crossref","unstructured":"Maruya S, Issa JP, Weber RS, et al. Differential methylation status of tumor-associated genes in head and neck squamous carcinoma: incidence and potential implications. Clin Cancer Res\u20082004;10:3825\u201330.","DOI":"10.1158\/1078-0432.CCR-03-0370"},{"key":"2022061105452105200_B32","doi-asserted-by":"crossref","unstructured":"Hasegawa M, Nelson HH, Peters E, Ringstrom E, Posner M, Kelsey KT. Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene\u20082002;21:4231\u20136.","DOI":"10.1038\/sj.onc.1205528"},{"key":"2022061105452105200_B33","unstructured":"Ogi K, Toyota M, Ohe-Toyota M, et al. Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma. Clin Cancer Res\u20082002;8:3164\u201371."},{"key":"2022061105452105200_B34","doi-asserted-by":"crossref","unstructured":"Youssef EM, Lotan D, Issa JP, et al. Hypermethylation of the retinoic acid receptor-\u03b2(2) gene in head and neck carcinogenesis. Clin Cancer Res\u20082004;10:1733\u201342.","DOI":"10.1158\/1078-0432.CCR-0989-3"},{"key":"2022061105452105200_B35","unstructured":"Nass SJ, Herman JG, Gabrielson E, et al. Aberrant methylation of the estrogen receptor and E-cadherin 5\u2032 CpG islands increases with malignant progression in human breast cancer. Cancer Res\u20082000;60:4346\u20138."},{"key":"2022061105452105200_B36","doi-asserted-by":"crossref","unstructured":"Nicoll G, Crichton DN, McDowell HE, Kernohan N, Hupp TR, Thompson AM. Expression of the hypermethylated in cancer gene (HIC-1) is associated with good outcome in human breast cancer. Br J Cancer\u20082001;85:1878\u201382.","DOI":"10.1054\/bjoc.2001.2163"},{"key":"2022061105452105200_B37","unstructured":"Eads CA, Lord RV, Wickramasinghe K, et al. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res\u20082001;61:3410\u20138."},{"key":"2022061105452105200_B38","doi-asserted-by":"crossref","unstructured":"Jeronimo C, Henrique R, Hoque MO, et al. A quantitative promoter methylation profile of prostate cancer. Clin Cancer Res\u20082004;10:8472\u20138.","DOI":"10.1158\/1078-0432.CCR-04-0894"},{"key":"2022061105452105200_B39","doi-asserted-by":"crossref","unstructured":"Tokumaru Y, Yamashita K, Osada M, et al. Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing. Cancer Res\u20082004;64:5982\u20137.","DOI":"10.1158\/0008-5472.CAN-04-0993"},{"key":"2022061105452105200_B40","unstructured":"Reddy AN, Jiang WW, Kim M, et al. Death-associated protein kinase promoter hypermethylation in normal human lymphocytes. Cancer Res\u20082003;63:7694\u20138."},{"key":"2022061105452105200_B41","doi-asserted-by":"crossref","unstructured":"Kulkarni V, Saranath D. Concurrent hypermethylation of multiple regulatory genes in chewing tobacco associated oral squamous cell carcinomas and adjacent normal tissues. Oral Oncol\u20082004;40:145\u201353.","DOI":"10.1016\/S1368-8375(03)00143-X"},{"key":"2022061105452105200_B42","doi-asserted-by":"crossref","unstructured":"Chang HW, Ling GS, Wei WI, Yuen AP. Smoking and drinking can induce p15 methylation in the upper aerodigestive tract of healthy individuals and patients with head and neck squamous cell carcinoma. Cancer\u20082004;101:125\u201332.","DOI":"10.1002\/cncr.20323"},{"key":"2022061105452105200_B43","unstructured":"Belinsky SA, Palmisano WA, Gilliland FD, et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res\u20082002;62:2370\u20137."},{"key":"2022061105452105200_B44","doi-asserted-by":"crossref","unstructured":"Nakahara Y, Shintani S, Mihara M, Hino S, Hamakawa H. Detection of p16 promoter methylation in the serum of oral cancer patients. Int J Oral Maxillofac Surg\u20082006;35:362\u20135.","DOI":"10.1016\/j.ijom.2005.08.005"},{"key":"2022061105452105200_B45","doi-asserted-by":"crossref","unstructured":"Hu YC, Sidransky D, Ahrendt SA. Molecular detection approaches for smoking associated tumors. Oncogene\u20082002;21:7289\u201397.","DOI":"10.1038\/sj.onc.1205805"},{"key":"2022061105452105200_B46","doi-asserted-by":"crossref","unstructured":"Ransohoff DF. Lessons from controversy: ovarian cancer screening and serum proteomics. J Natl Cancer Inst\u20082005;97:315\u20139.","DOI":"10.1093\/jnci\/dji054"},{"key":"2022061105452105200_B47","doi-asserted-by":"crossref","unstructured":"Adrien LR, Schlecht NF, Kawachi N, et al. Classification of DNA methylation patterns in tumor cell genomes using a CpG island microarray. Cytogenet Genome Res\u20082006;114:16\u201323.","DOI":"10.1159\/000091923"},{"key":"2022061105452105200_B48","unstructured":"Wei SH, Chen CM, Strathdee G, et al. Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers. Clin Cancer Res\u20082002;8:2246\u201352."}],"container-title":["Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/14\/1\/97\/1975019\/97.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/14\/1\/97\/1975019\/97.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T16:59:30Z","timestamp":1654966770000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article\/14\/1\/97\/196287\/Evaluation-of-Promoter-Hypermethylation-Detection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,1]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,1,2]]},"published-print":{"date-parts":[[2008,1,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1078-0432.ccr-07-0722","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/1078-0432.22440955.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22440955","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/1078-0432.c.6518167.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.c.6518167","asserted-by":"object"}]},"ISSN":["1078-0432","1557-3265"],"issn-type":[{"value":"1078-0432","type":"print"},{"value":"1557-3265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,1]]}}}